about
The evolution of genome-scale models of cancer metabolismCatabolic efficiency of aerobic glycolysis: the Warburg effect revisitedCancer as a metabolic diseaseShikonin directly targets mitochondria and causes mitochondrial dysfunction in cancer cells.Identification of small molecule inhibitors of pyruvate kinase M2SCaMC-1 promotes cancer cell survival by desensitizing mitochondrial permeability transition via ATP/ADP-mediated matrix Ca(2+) bufferingEpstein-Barr virus immortalization of human B-cells leads to stabilization of hypoxia-induced factor 1 alpha, congruent with the Warburg effectTyrosine phosphorylation of mitochondrial pyruvate dehydrogenase kinase 1 is important for cancer metabolismPhosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen speciesTargeting cellular metabolism to improve cancer therapeuticsGraviola: a novel promising natural-derived drug that inhibits tumorigenicity and metastasis of pancreatic cancer cells in vitro and in vivo through altering cell metabolismNext-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategyInsights into the Regulatory Role of Non-coding RNAs in Cancer MetabolismMitochondria, cholesterol and cancer cell metabolismMicroRNAs and oncogenic transcriptional regulatory networks controlling metabolic reprogramming in cancersOvercoming Hypoxia-Mediated Tumor Progression: Combinatorial Approaches Targeting pH Regulation, Angiogenesis and Immune DysfunctionHepatocellular carcinoma: Review of disease and tumor biomarkersMolecular Imaging of Metabolic Reprograming in Mutant IDH CellsEnergy metabolic dysfunction as a carcinogenic factor in cancer cellsMicrofabricated, amperometric, enzyme-based biosensors for in vivo applicationsInterplay Between Metabolism and Oncogenic Process: Role of microRNAsTargeting Tumor Metabolism for Cancer Treatment: Is Pyruvate Dehydrogenase Kinases (PDKs) a Viable Anticancer Target?Gamma-enolase: a well-known tumour marker, with a less-known role in cancer6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signallingCancer Metabolism and Drug ResistanceDysregulated metabolism contributes to oncogenesisOvarian clear cell carcinoma meets metabolism; HNF-1β confers survival benefits through the Warburg effect and ROS reductionMetabolic interplay between glycolysis and mitochondrial oxidation: The reverse Warburg effect and its therapeutic implicationVoltage-gated sodium channels and cancer: is excitability their primary role?Transcriptional regulation of chemokine expression in ovarian cancerIs cancer a metabolic disease?Lactate shuttles at a glance: from physiological paradigms to anti-cancer treatmentsRestoration of mitochondria function as a target for cancer therapyTranslational metabolomics in cancer researchThe genetic and epigenetic alterations in human hepatocellular carcinoma: a recent updateFunctional O-GlcNAc modifications: implications in molecular regulation and pathophysiologyHow does the metabolism of tumour cells differ from that of normal cellsViruses in cancer cell plasticity: the role of hepatitis C virus in hepatocellular carcinomaMetabolic and hypoxic adaptation to anti-angiogenic therapy: a target for induced essentialityTargeting glycogen metabolism in bladder cancer
P2860
Q21129241-50B480A0-E717-4E6C-8668-A967B5F2FC4FQ21202785-B8FD227F-469A-4733-AEF8-66D642EFF110Q21245061-DB245381-DF14-4F40-95BD-770904A4C4AEQ21284985-CF2CD042-F3AB-4019-88BD-81125A1FEE23Q22001512-F4357C22-BACD-4D20-96D8-FCDACE891DB5Q24294177-AAC8C14C-8AA8-46FB-BEE4-A01E844622D4Q24294513-A73815F7-572F-4E45-ABED-69828B599DFAQ24300524-C328BADC-DB99-46B5-9FEA-4E747F1E26C0Q24305112-AB5FC0D0-1AF5-4B54-B316-F5F263D5E8B4Q24596727-700D2231-ED86-4DFF-83CF-685EF7C65AFBQ24608066-07D1125E-EA58-4B06-943A-FE52ADE3AF8BQ24628724-A70920E3-18C4-49DF-B3A9-B195F38CE4F3Q26739857-C8B035DB-26A5-4A51-9606-1BA6050A65AAQ26741708-403B2031-50B6-4CFB-B46D-0582BC844C51Q26745980-96AB94EC-10FF-4A4E-9D03-B3294F1BD8C5Q26749333-C40F6955-696E-4111-9EBD-F726137FD645Q26750796-A019DA90-F353-495A-96EF-E36A0713EA2BQ26750861-00574B7B-F304-4753-8708-24CA05979049Q26751065-29C5332E-6DE7-487E-808B-CCBD6501259AQ26764976-B53CF5C7-5598-4150-A1E4-EFBA08C092E0Q26770381-3602384A-009A-43EC-A9F3-CE87FEA582A9Q26774957-5480DA78-B18E-4109-AA3F-62D4BD6C5A54Q26781703-9B993552-245F-4E07-874F-CB2D7988F488Q26781896-E15766E2-2EDA-4A1B-A3A0-4AA75D6FBAA5Q26782042-0EDE337D-1390-4A57-8848-6A18F29E5025Q26784630-8AB1A3DE-53F5-4565-A75B-6DDD9D2584A6Q26786610-FDD69941-C24F-4A11-B187-3316E629D17BQ26795759-749ADBB5-765D-4BF7-B560-B04E6F1C3F04Q26797387-F040E9D9-89F7-4A5F-9A80-8DB761D68991Q26825361-48E45132-01AE-4B13-9B45-11E6ECFFF528Q26852241-E3314F80-85A7-479D-A467-8D299EA78B08Q26863243-6B0A9C5E-9C84-4FAE-B115-90F00F9AF8E2Q26864167-87830FF2-0E75-4414-B5E6-505F6DEE2AC0Q26998663-688F84D2-FD05-4DA6-8848-16DF78D838D6Q27003050-05A8B8E4-A37A-4638-AEE7-AFA410CA98C8Q27009399-2665A0AC-0EA7-4751-8DA7-791ED7893FC7Q27011856-B144FA5C-1127-4034-A78D-855C87310EC4Q27012614-A341888E-5A64-423D-B999-E4C20226206AQ27025007-DFDBACEA-A526-4551-AC5B-9073B67FF7CFQ27025144-1BC2DB26-B338-468D-AA29-A8645F66A0D1
P2860
description
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2008
@ast
im Juni 2008 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: June 2008)
@en
wetenschappelijk artikel (gepubliceerd in 2008-06)
@nl
наукова стаття, опублікована в червні 2008
@uk
مقالة علمية (نشرت في يونيو 2008)
@ar
name
Tumor cell metabolism: cancer's Achilles' heel
@ast
Tumor cell metabolism: cancer's Achilles' heel
@en
type
label
Tumor cell metabolism: cancer's Achilles' heel
@ast
Tumor cell metabolism: cancer's Achilles' heel
@en
prefLabel
Tumor cell metabolism: cancer's Achilles' heel
@ast
Tumor cell metabolism: cancer's Achilles' heel
@en
P3181
P1433
P1476
Tumor cell metabolism: cancer's Achilles' heel
@en
P2093
Pouyssegur J
P304
P3181
P356
10.1016/J.CCR.2008.05.005
P407
P577
2008-06-01T00:00:00Z